Advertisement
Advertisement
IMCC
IM Cannabis Corp. Common Shares
0.92
USDSponsored
+0.08
+9.97%
Mar 12, 15:52 UTC -4
Closed
Pre-Market
0.89
-0.03
-2.83%
IMCC Earnings Reports
Positive Surprise Ratio
IMCC beat 6 of 16 last estimates.
38%
Next Report
Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
$22.93M
/$0.12
Implied change from Q3 25 (Revenue/ EPS)
--
/--
Implied change from Q4 24 (Revenue/ EPS)
+71.97%
/-154.55%
IM Cannabis Corp. Common Shares earnings per share and revenue
On Nov 13, 2025, IMCC reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.03 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 20.89 million, with a --% difference.
Looking ahead to Q4 25, 3 analysts forecast an EPS of 0.12 USD, with revenue projected to reach 22.93 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
Myomo Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.08
Surprise
+2.19%
Cellectar Biosciences INC NEW
Report Date
Mar 04, 2026 For Q4 25
Estimate
-$2.33
Actual
-$1.29
Surprise
+44.85%
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.14
Surprise
+6.63%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
Viemed Healthcare, Inc. Common Shares
Report Date
Mar 04, 2026 For Q4 25
Estimate
$0.12
Actual
$0.14
Surprise
+10.85%
Apyx Medical Corporation Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.63%
MacroGenics, Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.29
Actual
-$0.23
Surprise
+22.40%
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
FAQ
What were IM Cannabis Corp. Common Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, IM Cannabis Corp. Common Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to IM Cannabis Corp. Common Shares's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is IM Cannabis Corp. Common Shares expected to report next?
The next earning report is scheduled for Mar 30, 2026.
What are the forecasts for IM Cannabis Corp. Common Shares's next earnings report?
Based on 3
analysts, IM Cannabis Corp. Common Shares is expected to report EPS of $0.12 and revenue of $22.93M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement